Inventor · disambiguated record
Francesca Schiaretti
Also filed as: SCHIARETTI FRANCESCA
12 granted patents·4 pending applications·26 citations·filing 2011–2021
86Inventor score
Top patents by PatentIndex Score
16 records- 0185US9808422B2Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalationCHIESI FARM SPA·Filed 2016·Granted Nov 7, 2017·7 cites·15 claims
- 0285US9402825B2Dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergic for administration by inhalationCHIESI FARM SPA·Filed 2014·Granted Aug 2, 2016·11 cites·16 claims
- 0378US10350164B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2018·Granted Jul 16, 2019·2 cites·20 claims
- 0477US10086004B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2016·Granted Oct 2, 2018·2 cites·18 claims
- 0572US9132121B2Dry powder formulation comprising a phosphodiesterase inhibitorCOCCONI DANIELA·Filed 2011·Granted Sep 15, 2015·4 cites·22 claims
- 0670US11628175B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2021·Granted Apr 18, 2023·0 cites·10 claims
- 0768US10966991B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2020·Granted Apr 6, 2021·0 cites·18 claims
- 0868US10772896B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2018·Granted Sep 15, 2020·0 cites·18 claims
- 0957US10583085B2Carrier particles for dry powder formulations for inhalationCHIESI FARM SPA·Filed 2018·Granted Mar 10, 2020·0 cites·15 claims
- 1052US10709666B2Carrier particles for dry powder formulations for inhalationCHIESI FARM SPA·Filed 2020·Granted Jul 14, 2020·0 cites·2 claims
- 1147US2018133161A1Use of magnesium stearate in dry powder formulations for inhalationCHIESI FARM SPA·Filed 2018·Application pending·0 cites
- 1246US9308200B2Dry powder formulation comprising a phosphodiesterase inhibitorCHIESI FARMA SPA·Filed 2015·Granted Apr 12, 2016·0 cites·20 claims
- 1340US2015320691A1Use of magnesium stearate in dry powder formulations for inhalationCHIESI FARMA SPA·Filed 2015·Application pending·0 cites
- 1438US2012082727A1Use of magnesium stearate in dry powder formulations for inhalationCOCCONI DANIELA·Filed 2011·Application pending·0 cites
- 1536US10786450B2Process for preparing a dry powder formulation comprising an anticholinergic, a corticosteroid and a beta-adrenergicCHIESI FARM SPA·Filed 2018·Granted Sep 29, 2020·0 cites·16 claims
- 1636US2011308519A1Dry powder formulation comprising an antimuscarinic drugSCHIARETTI FRANCESCA·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →